The effects of L-carnitine on presbyacusis in the rat model

Clinical Otolaryngology and Allied Sciences

Volumn 29, Issue 3, 2004, Pages 238-241

  Derin, A ^a   Agirdir, B ^a   Derin, N ^a   Dinc O ^a   Guney K ^a   Ozcaglar, H ^a   Kilincarslan S ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Ageing; Auditory brainstem response; L carnitine; Reactive oxygen metabolites

Indexed keywords

CARNITINE; REACTIVE OXYGEN METABOLITE; URETHAN; WATER;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY NERVOUS SYSTEM; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; EVOKED BRAIN STEM AUDITORY RESPONSE; GENETIC DAMAGE; GENOME; LATENT PERIOD; MALE; NONHUMAN; PRESBYACUSIS; PRIORITY JOURNAL; RAT; TISSUE INJURY;

AGING; ANIMALS; AUDITORY THRESHOLD; CARNITINE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FREE RADICAL SCAVENGERS; MALE; MODELS, ANIMAL; PRESBYCUSIS; RANDOM ALLOCATION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 2542461313     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2273.2004.00790.x     Document Type: Article

References (15)

1. MILLS J.H. (1991) Presbyacusis. In Otorhinolaryngology Head and Neck Surgery, BALLENGER J.J. (ed.), pp. 1133-1141. Lea & Febgier, Philadelphia, PA
2. SEIDMAN M.D., KHAN M.J., UMA B. et al. (2000) Biologic activity of mitochondrial metabolites on aging and age-related hearing loss. Am. J. Otolaryngol. Head Neck Surg. 2, 161-167
3. HAECKEL R., KAISER E., OELLERICH M. et al. (1990) Carnitine: metabolism, function and clinical application. J. Clin. Chem. Clin. Biochem. 28, 291-295
4. DE SIMONE C., FERRARI M., LOZZI A. et al. (1982) Vitamins and immunity. II. Influence of L-carnitine on the immune system. Acta Vitaminol. Enzymol. 4, 135
5. DE SIMONE C., FERRARI M., MELI D. et al. (1982) Reversibility by L-carnitine of immunosuppression induced by an emulsion of soya bean oil, glyserol and egg lecithin. Arzneim Forsch/Drug Res. 32, 1485
6. FAMULARO G., MATRICARDI F., NUCERA E. et al. (1997) Carnitine deficiency. Primary and secondary syndromes. Molecular biology intelligence unit. In Carnitine Today, SIMONE DE C. & FAMULARA G. (eds), pp. 119-161. Austin, TX
7. NEUMANN F.J., OTT I., GAWAZ M et al. (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92, 748-755
8. HÜLSMANN W.C. & DUBELAAR M.L. (1992) Carnitine recruitment of vascular endothelial and smooth muscle cells in imminent ischemia. Mol. Cell. Biochem. 116, 125-129
9. GEREMIA E., SANTORO C., BARATTA D. et al. (1988) Antioxidant action of asetil L-camitine: in vitro study. Med. Sci. Res. 16, 699-700
10. DI GIACOMO C., LATTERI F., SORRENTY V. et al. (1993) Effect of asetil L-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle. Neuro. Chem. Res. 18, 1157-1162
11. REZNICK A.Z., KAGAN V.E., RAMSEY R. et al. (1992) Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation. Arch. Biochem. Biophys. 296, 394-401
12. STAPELLS U. (1989) Auditory brainstem response assessment of infants and children. Semin. Hear. 10, 229-251
13. FRED F.T., THIERRI M., MARK A. et al. (1999) Comparison of the auditory-evoked brainstem response wave I to DPOAE resulting from changes to inner ear blood flow. Laryngoscope 109, 186-191
14. SIEDMAN M.D. (2000) Effects of dietary restriction and antioxidants on presbyacusis. Laryngoscope 110, 727-738
15. TANPHAICHITR V. & LEELAHAGUL P. (1993) Carnitine metabolism and human carnitine deficiency. Nutrition 9, 246-254